Teleflex Incorporated (TFX) Shares Bought by BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 14.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 16,543 shares of the medical technology company’s stock after buying an additional 2,035 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp’s holdings in Teleflex were worth $4,116,000 as of its most recent filing with the SEC.

Other institutional investors have also bought and sold shares of the company. Aristotle Atlantic Partners LLC bought a new position in shares of Teleflex during the 4th quarter worth approximately $202,000. Quantitative Systematic Strategies LLC bought a new position in shares of Teleflex during the 4th quarter worth approximately $228,000. Checchi Capital Advisers LLC bought a new position in shares of Teleflex during the 4th quarter worth approximately $230,000. Coldstream Capital Management Inc. bought a new position in shares of Teleflex during the 3rd quarter worth approximately $226,000. Finally, Lourd Capital LLC bought a new position in shares of Teleflex during the 4th quarter worth approximately $266,000. Hedge funds and other institutional investors own 90.75% of the company’s stock.

Shares of TFX opened at $254.98 on Monday. Teleflex Incorporated has a 12-month low of $191.04 and a 12-month high of $288.78. The company has a current ratio of 2.33, a quick ratio of 1.51 and a debt-to-equity ratio of 0.89. The firm has a market capitalization of $11,486.59, a P/E ratio of 30.35, a PEG ratio of 1.89 and a beta of 1.22.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, February 22nd. The medical technology company reported $2.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.40 by $0.04. Teleflex had a return on equity of 16.46% and a net margin of 7.11%. The company had revenue of $595.10 million for the quarter, compared to analysts’ expectations of $601.17 million. During the same period last year, the business earned $2.13 EPS. Teleflex’s quarterly revenue was up 15.8% compared to the same quarter last year. sell-side analysts forecast that Teleflex Incorporated will post 9.66 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Thursday, March 15th. Investors of record on Friday, March 2nd were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.53%. The ex-dividend date of this dividend was Thursday, March 1st. Teleflex’s dividend payout ratio is currently 16.19%.

In other Teleflex news, Director Stephen K. M.D. Klasko sold 200 shares of the firm’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $276.44, for a total transaction of $55,288.00. Following the transaction, the director now directly owns 8,080 shares in the company, valued at approximately $2,233,635.20. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director George Babich, Jr. sold 2,500 shares of the firm’s stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $263.38, for a total value of $658,450.00. Following the transaction, the director now owns 10,583 shares in the company, valued at $2,787,350.54. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 16,759 shares of company stock worth $4,396,861. Company insiders own 2.39% of the company’s stock.

A number of equities analysts have issued reports on TFX shares. TheStreet cut Teleflex from an “a-” rating to a “c+” rating in a report on Monday, March 12th. Stephens reiterated a “buy” rating and issued a $300.00 target price on shares of Teleflex in a report on Thursday, January 18th. Leerink Swann cut their target price on Teleflex from $321.00 to $300.00 and set an “outperform” rating on the stock in a report on Friday, February 23rd. Finally, ValuEngine cut Teleflex from a “buy” rating to a “hold” rating in a report on Wednesday, March 7th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and six have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $281.56.

ILLEGAL ACTIVITY NOTICE: “Teleflex Incorporated (TFX) Shares Bought by BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp” was published by WKRB News and is owned by of WKRB News. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.wkrb13.com/2018/04/02/teleflex-incorporated-tfx-shares-bought-by-british-columbia-investment-management-corp.html.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply